Related Experiment Videos
[Analysis of continuous hemodiafiltration after open heart surgery]
N Sakagoshi1, H Yasuda, T Yonemoto
1Department of Cardiovascular Surgery, Kawachi General Hospital, Higashi-osaka, Japan.
Kyobu Geka. the Japanese Journal of Thoracic Surgery
|March 15, 2003
Summary
Continuous hemodiafiltration (CHDF) effectively treated renal failure in patients post-open heart surgery. While mortality remains a concern, CHDF demonstrated significant benefits for kidney function and fluid balance in this cohort.
Area of Science:
- Nephrology
- Cardiovascular Surgery
- Critical Care Medicine
Context:
- Post-open heart surgery renal failure presents a significant mortality risk.
- Continuous hemodiafiltration (CHDF) is a potential treatment modality for acute kidney injury in surgical patients.
Purpose:
- To evaluate the efficacy and safety of CHDF in managing renal failure following open heart surgery.
- To assess patient outcomes, including survival and recovery from renal dysfunction.
Summary:
- Thirteen patients undergoing open heart surgery with subsequent renal failure were treated with CHDF between April 1999 and December 2001.
- Indications for CHDF included blood purification (8 patients) and fluid management (5 patients).
- Seven patients successfully weaned off CHDF, with five discharged; however, two later died of cerebral infarction. Two patients required transition to hemodialysis, and two died from complications including sepsis and multi-organ failure.
Impact:
- CHDF proved effective in treating renal failure post-cardiac surgery without adversely affecting hemodynamic status.
- The study highlights CHDF as a valuable tool for managing acute kidney injury in this high-risk surgical population.
- Mortality remains a challenge, but CHDF offers a viable option for renal support and fluid balance.